Green Alpha Advisors, LLC Editas Medicine, Inc. Transaction History

Green Alpha Advisors, LLC

$124 Million
Q3 2024

A detailed history of Green Alpha Advisors, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 43,333 shares of EDIT stock, worth $56,766. This represents 0.12% of its overall portfolio holdings.

Number of Shares

43,333

Previous 30,267 43.17%

Holding current value

$56,766

Previous $141,000 4.26%

% of portfolio

0.12%

Previous 0.12%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$3.39 - $5.96 $44,293 - $77,873	13,066 Added 43.17%	43,333 $147,000
Q2 2024 Aug 13, 2024	SELL	$4.67 - $7.28 $73,870 - $115,155	-15,818 Reduced 34.32%	30,267 $141,000
Q1 2024 Apr 09, 2024	BUY	$7.03 - $11.07 $1,145 - $1,804	163 Added 0.35%	46,085 $341,000
Q4 2023 Jan 04, 2024	SELL	$6.25 - $11.11 $195,412 - $347,365	-31,266 Reduced 40.51%	45,922 $465,000
Q3 2023 Oct 10, 2023	BUY	$6.92 - $9.31 $106,173 - $142,843	15,343 Added 24.81%	77,188 $602,000
Q2 2023 Jul 06, 2023	BUY	$6.36 - $11.47 $20,186 - $36,405	3,174 Added 5.41%	61,845 $508,000
Q1 2023 Apr 06, 2023	SELL	$7.03 - $11.53 $6,917 - $11,345	-984 Reduced 1.65%	58,671 $425,000
Q4 2022 Jan 12, 2023	BUY	$8.32 - $13.21 $23,770 - $37,740	2,857 Added 5.03%	59,655 $0
Q3 2022 Oct 14, 2022	SELL	$12.16 - $19.42 $3.44 Million - $5.5 Million	-283,146 Reduced 83.29%	56,798 $695,000
Q2 2022 Jul 08, 2022	BUY	$9.99 - $21.35 $2.91 Million - $6.22 Million	291,531 Added 602.18%	339,944 $4.02 Million
Q1 2022 Apr 19, 2022	BUY	$14.08 - $27.63 $171,761 - $337,058	12,199 Added 33.69%	48,413 $921,000
Q4 2021 Jan 12, 2022	BUY	$26.55 - $40.57 $120,855 - $184,674	4,552 Added 14.38%	36,214 $961,000
Q3 2021 Oct 12, 2021	BUY	$39.27 - $72.94 $28,941 - $53,756	737 Added 2.38%	31,662 $1.3 Million
Q2 2021 Jul 22, 2021	BUY	$31.29 - $56.64 $637,439 - $1.15 Million	20,372 Added 193.04%	30,925 $1.75 Million
Q1 2021 Jul 22, 2021	BUY	$39.71 - $90.58 $179,370 - $409,149	4,517 Added 74.83%	10,553 $443,000
Q4 2020 Jul 22, 2021	BUY	$27.07 - $84.35 $163,394 - $509,136	6,036 New	6,036 $423,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Account

Green Alpha Advisors, LLC Editas Medicine, Inc. Transaction History